1. Home
  2. RIGL vs NNOX Comparison

RIGL vs NNOX Comparison

Compare RIGL & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RIGL
  • NNOX
  • Stock Information
  • Founded
  • RIGL 1996
  • NNOX 2011
  • Country
  • RIGL United States
  • NNOX Israel
  • Employees
  • RIGL N/A
  • NNOX N/A
  • Industry
  • RIGL Biotechnology: Pharmaceutical Preparations
  • NNOX Medical Electronics
  • Sector
  • RIGL Health Care
  • NNOX Health Care
  • Exchange
  • RIGL Nasdaq
  • NNOX Nasdaq
  • Market Cap
  • RIGL 335.5M
  • NNOX 248.7M
  • IPO Year
  • RIGL 2000
  • NNOX 2020
  • Fundamental
  • Price
  • RIGL $38.85
  • NNOX $3.85
  • Analyst Decision
  • RIGL Buy
  • NNOX Strong Buy
  • Analyst Count
  • RIGL 5
  • NNOX 2
  • Target Price
  • RIGL $38.20
  • NNOX $8.50
  • AVG Volume (30 Days)
  • RIGL 995.6K
  • NNOX 1.3M
  • Earning Date
  • RIGL 08-05-2025
  • NNOX 08-12-2025
  • Dividend Yield
  • RIGL N/A
  • NNOX N/A
  • EPS Growth
  • RIGL N/A
  • NNOX N/A
  • EPS
  • RIGL 5.43
  • NNOX N/A
  • Revenue
  • RIGL $267,921,000.00
  • NNOX $11,886,000.00
  • Revenue This Year
  • RIGL $59.93
  • NNOX $24.12
  • Revenue Next Year
  • RIGL N/A
  • NNOX $160.56
  • P/E Ratio
  • RIGL $7.15
  • NNOX N/A
  • Revenue Growth
  • RIGL 105.62
  • NNOX 17.36
  • 52 Week Low
  • RIGL $12.66
  • NNOX $3.75
  • 52 Week High
  • RIGL $43.72
  • NNOX $11.00
  • Technical
  • Relative Strength Index (RSI)
  • RIGL 68.57
  • NNOX 32.78
  • Support Level
  • RIGL $39.00
  • NNOX $3.88
  • Resistance Level
  • RIGL $42.08
  • NNOX $4.16
  • Average True Range (ATR)
  • RIGL 2.32
  • NNOX 0.19
  • MACD
  • RIGL -0.37
  • NNOX -0.02
  • Stochastic Oscillator
  • RIGL 53.26
  • NNOX 8.44

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

About NNOX NANO-X IMAGING LTD

Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.

Share on Social Networks: